Analysis of serum ErbB-2 protein and HLA-DRB1 in Japanese patients with lung cancer
- 5 April 2000
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 152 (1), 87-95
- https://doi.org/10.1016/s0304-3835(99)00437-1
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomasBritish Journal of Cancer, 1995
- Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients.Journal of Clinical Oncology, 1992
- p53 function and dysfunctionCell, 1992
- Toward the Primary Prevention of CancerScience, 1991
- Histocompatibility locus antigens (HLA) in the epidermoid type of lung carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 1990
- In vitro and in vivo Release of Soluble erbB‐2 Protein from Human Carcinoma CellsJapanese Journal of Cancer Research, 1990
- Induction of a variety of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659----Glu659).The EMBO Journal, 1990
- Mutational Activation of the K-rasOncogeneNew England Journal of Medicine, 1987
- Amplification and expression of the c-myc oncogene in human lung cancer cell linesNature, 1983
- Prolonged disease-free survival in bronchogenic carcinoma associated with HLA-Aw19 and HLA-B5:A two-year prospective studyCancer, 1977